| Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8+ T cells M Enamorado, S Iborra, E Priego, FJ Cueto, JA Quintana, ... Nature communications 8 (1), 16073, 2017 | 272 | 2017 |
| Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern PR Wratil, M Stern, A Priller, A Willmann, G Almanzar, E Vogel, ... Nature medicine 28 (3), 496-503, 2022 | 239 | 2022 |
| The evolution of poxvirus vaccines L Sánchez-Sampedro, B Perdiguero, E Mejías-Pérez, J García-Arriaza, ... Viruses 7 (4), 1726-1803, 2015 | 230 | 2015 |
| MicroRNAs are minor constituents of extracellular vesicles that are rarely delivered to target cells M Albanese, YFA Chen, C Hüls, K Gärtner, T Tagawa, E Mejias-Perez, ... PLoS Genetics 17 (12), e1009951, 2021 | 180 | 2021 |
| Distinct roles of vaccinia virus NF-κB inhibitor proteins A52, B15, and K7 in the immune response M Di Pilato, E Mejías-Pérez, COS Sorzano, M Esteban Journal of virology 91 (13), 10.1128/jvi. 00575-17, 2017 | 53 | 2017 |
| NFκB activation by modified vaccinia virus as a novel strategy to enhance neutrophil migration and HIV-specific T-cell responses M Di Pilato, E Mejías-Pérez, M Zonca, B Perdiguero, CE Gómez, ... Proceedings of the National Academy of Sciences 112 (11), E1333-E1342, 2015 | 40 | 2015 |
| High Quality Long-Term CD4+ and CD8+ Effector Memory Populations Stimulated by DNA-LACK/MVA-LACK Regimen in Leishmania major BALB/c Model of … L Sanchez-Sampedro, CE Gómez, E Mejias-Perez, CO S. Sorzano, ... PloS one 7 (6), e38859, 2012 | 38 | 2012 |
| Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140 (ZM96) and Gag (ZM96)-Pol-Nef (CN54 … B Perdiguero, CE Gómez, V Cepeda, L Sánchez-Sampedro, ... Journal of virology 89 (2), 970-988, 2015 | 34 | 2015 |
| New vaccinia virus promoter as a potential candidate for future vaccines M Di Pilato, E Mejías-Pérez, CE Gomez, B Perdiguero, COS Sorzano, ... Journal of General Virology 94 (12), 2771-2776, 2013 | 33 | 2013 |
| Development of a safe and effective vaccinia virus oncolytic vector WR-Δ4 with a set of gene deletions on several viral pathways E Mejías-Pérez, L Carreño-Fuentes, M Esteban Molecular Therapy-Oncolytics 8, 27-40, 2018 | 28 | 2018 |
| Rapid, efficient and activation-neutral gene editing of polyclonal primary human resting CD4+ T cells allows complex functional analyses M Albanese, A Ruhle, J Mittermaier, E Mejías-Pérez, M Gapp, A Linder, ... Nature methods 19 (1), 81-89, 2022 | 22 | 2022 |
| Modification of promoter spacer length in vaccinia virus as a strategy to control the antigen expression M Di Pilato, L Sanchez-Sampedro, E Mejías-Pérez, COS Sorzano, ... Journal of General Virology 96 (8), 2360-2371, 2015 | 19 | 2015 |
| Attenuated and replication-competent vaccinia virus strains M65 and M101 with distinct biology and immunogenicity as potential vaccine candidates against pathogens L Sánchez-Sampedro, CE Gómez, E Mejías-Pérez, E Pérez-Jiménez, ... Journal of Virology 87 (12), 6955-6974, 2013 | 19 | 2013 |
| The evolution of poxvirus vaccines. Viruses 7: 1726–1803 L Sánchez-Sampedro, B Perdiguero, E Mejías-Pérez, J García-Arriaza, ... Article CAS PubMed PubMed Central, 2015 | 15 | 2015 |
| Suppression of SARS‐CoV‐2 Replication with Stabilized and Click‐Chemistry Modified siRNAs FR Traube, M Stern, AJ Tölke, M Rudelius, E Mejías‐Pérez, N Raddaoui, ... Angewandte Chemie International Edition 61 (38), e202204556, 2022 | 10 | 2022 |
| Neutrophil subtypes shape HIV-specific CD8 T-cell responses after vaccinia virus infection M Di Pilato, M Palomino-Segura, E Mejías-Pérez, CE Gómez, ... npj Vaccines 6 (1), 52, 2021 | 9 | 2021 |
| Superior immunity that allows neutralization of all SARS-CoV-2 variants of concern develops in COVID-19 convalescents and naïve individuals after three vaccinations U Protzer, P Wratil, M Stern, A Priller, A Willmann, G Almanzar, E Vogel, ... | 6 | 2022 |
| A Prime/Boost PfCS14KM/MVA-sPfCSM Vaccination Protocol Generates Robust CD8+ T Cell and Antibody Responses to Plasmodium falciparum … A Vijayan, E Mejías-Pérez, DA Espinosa, SC Raman, COS Sorzano, ... Clinical and Vaccine Immunology 24 (5), e00494-16, 2017 | 5 | 2017 |
| NYVAC vector modified by C7L viral gene insertion improves T cell immune responses and effectiveness against leishmaniasis L Sanchez-Sampedro, E Mejias-Perez, CÓS Sorzano, JL Najera, ... Virus research 220, 1-11, 2016 | 4 | 2016 |
| Spatial resolution of HIV-1 post-entry steps in resting CD4 T cells S Ananth, I Ambiel, S Schifferdecker, TG Müller, PR Wratil, E Mejias-Perez, ... Cell Reports 43 (3), 2024 | 2 | 2024 |
